Emerging Role of ImmunoPET in Receptor Targeted Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|8|1|70-78

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.8, Iss.1, 2011-01, pp. : 70-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 3, 2008-06 ,pp. : 231-234

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for targeted therapy of bladder cancer

By Agarwal Piyush K   Black Peter C   McConkey David J   Dinney Colin PN  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 435-448

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics Opportunities in Nuclear Receptor Targeted Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 2, Iss. 3, 2002-01 ,pp. : 243-256

Bentham Science Publishers

Access to resources Recommend Favorite

Somatostatin Receptor-Targeted Anti-Cancer Therapy

By  

Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite

The Emerging Role of the Histamine H4 Receptor in Anti-inflammatory Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-07 ,pp. : 1365-1373

Bentham Science Publishers

Access to resources Recommend Favorite